Session 1: Diabetes Update: Evidence Based Approaches to the Management of Type 2 Diabetes |
||||||
|
||||||
C. Wayne Weart,Pharm.D., FASHP,FAPhA, BCPS Dr. Weart is on the speakers bureau for Novartis, in the area of hypertension and Pfizer in the areas of cardiovascular disease and pain. He is a consultant for Merck in the area of outcomes research. |
At the conclusion of this program, the participant will be able to:
|
|||||







